Fracture Data Spurs Medtronic To Suspend Sales Of Fidelis ICD Lead
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's decision to halt worldwide distribution of its Sprint Fidelis defibrillator leads has attracted congressional scrutiny of the company's response to data showing the leads were vulnerable to fracture